Karmanos Caner Center

Detroit, Michigan 48201

0 studies enrolling now · 1 studies all time

What they study most

Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) — Stopped early